Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for chemotherapy-induced peripheral neuropathy
IRCT20201128049515N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Mazandaran University of Medical Sciences. Started Dec 2020; status: completed.
02
Drugs
silymarin
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20201128049515N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201128049515N1.